Jeremy D. Baker

University of Puget Sound — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

19h-index1.5kcitations46works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Heat shock proteins research(12), Signaling Pathways in Disease(10), Alzheimer's disease research and treatments(9), Endoplasmic Reticulum Stress and Disease(5), RNA Research and Splicing(4)

Publications45 total

Mastoiditis
American Academy of PediatricsItasca, IL eBooks·2023
Tau–RNA complexes inhibit microtubule polymerization and drive disease-relevant conformation change
Brain·2023· 28 citedOpen Access
The role of Tau RNA complex formation in tau function and tauopathy disorders
Alzheimer s & Dementia·2022
CONNECT 2021 CLOSING CEREMONY
2021
Correction to: Hsp90 co‑chaperones, FKBP52 and Aha1, promote tau pathogenesis in aged wild‑type mice
Acta Neuropathologica Communications·2021· 3 citedOpen Access
Hsp90 co-chaperones, FKBP52 and Aha1, promote tau pathogenesis in aged wild-type mice
Acta Neuropathologica Communications·2021· 51 citedOpen Access
Aberrant AZIN2 and polyamine metabolism precipitates tau neuropathology
Journal of Clinical Investigation·2021· 42 citedOpen Access
A drug repurposing screen identifies hepatitis C antivirals as inhibitors of the SARS-CoV2 main protease
PLoS ONE·2021· 53 citedOpen Access
Inhibition of the MSUT2: RNA interaction for the treatment of tauopathies
Alzheimer s & Dementia·2020Open Access
Chaperone imbalance drives tau pathogenesis
Alzheimer s & Dementia·2020· 2 citedOpen Access
Catalysis of proline isomerization and molecular chaperone activity in a tug-of-war
Nature Communications·2020· 36 citedOpen Access
Author Reply to Peer Reviews of A drug repurposing screen identifies hepatitis C antivirals as inhibitors of the SARS-CoV-2 main protease
2020
AlphaScreen Identifies MSUT2 Inhibitors for Tauopathy-Targeting Therapeutic Discovery
SLAS DISCOVERY·2020· 4 citedOpen Access
A drug repurposing screen identifies hepatitis C antivirals as inhibitors of the SARS-CoV-2 main protease
2020· 13 citedOpen Access
Targeting Pathological Tau by Small Molecule Inhibition of the Poly(A):MSUT2 RNA–Protein Interaction
ACS Chemical Neuroscience·2020· 25 citedOpen Access
The Molecular Basis of the Interaction of Cyclophilin A with α‐Synuclein
Angewandte Chemie International Edition·2019· 29 citedOpen Access
The Molecular Basis of the Interaction of Cyclophilin A with α‐Synuclein
Angewandte Chemie·2019Open Access
Spermidine/spermine-N1-acetyltransferase ablation impacts tauopathy-induced polyamine stress response
Alzheimer s Research & Therapy·2019· 49 citedOpen Access
Structure and Pro-toxic Mechanism of the Human Hsp90/PPIase/Tau Complex (P1.1-006)
Neurology·2019
Structure and pro-toxic mechanism of the human Hsp90/PPIase/Tau complex.
RePEc: Research Papers in Economics·2019Open Access
page 1 of 3Next →

Frequent Co-authors

Laura J. Blair(25), Chad A. Dickey(20), Dali Zheng(9), Lindsey B. Shelton(9), John Koren(8), Markus Zweckstetter(8), Brian C. Kraemer(8), Jonathan J. Sabbagh(7), April L. Darling(7), Rikki L. Uhrich(7), Bryce A. Nordhues(5), Vladimir N. Uversky(5), Sarah N. Fontaine(4), Mackenzie D. Martin(4), Filippo Favretto(4), Stefan Becker(4), Marangelie Criado‐Marrero(4), Niat T. Gebru(4), Timothy J. Strovas(4), Jack M. Webster(3)